Individualised quality of life as a measure to guide treatment choices in squamous cell carcinoma of the head and neck

More than 90% of all head and neck cancers are squamous cell carcinomas [1], which encompass epithelial cancers of the oral cavity, sinuses, nasopharynx, pharynx and larynx. In 2012, the global incidence of squamous cell carcinoma of the head and neck (SCCHN) was 7% [2], with more than 600,000 cases reported worldwide per year, making it the sixth most common cancer in the world [2–4]. Known risk factors for SCCHN are alcohol consumption and smoking; infection with human papillomavirus (HPV), primarily HPV-16, has also been mainly associated with cancer of the oropharynx [5].
Source: Oral Oncology - Category: Cancer & Oncology Authors: Tags: Review Source Type: research